Tumor-specific pathway identified

November 22, 2011, UT Southwestern Medical Center

A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.

Dr. Ralph DeBerardinis, senior author of the study published Nov. 20 in Nature, likened the newly discovered pathway to traffic that is rerouted during a highway construction project.

"If we hone in on this reverse pathway, then we may be able to prevent the growth of certain ," said Dr. DeBerardinis, assistant professor of pediatrics and a physician scientist in the Eugene McDermott Center for Human Growth and Development. "It's long been thought that targeting tumor-specific would lead to an effective way to treat cancer. This is one of the few metabolic pathways that may actually exist specifically in tumors."

The pathway involves the Krebs cycle, a series of that generates energy and is considered one of the most familiar and widely studied processes in biology. In the normal cycle, energy is derived by the breakdown of from ingested carbohydrates, fats and proteins into carbon dioxide and water.

For more than 70 years, biology textbooks have depicted the Krebs cycle as running clockwise in . UT Southwestern researchers found that in some tumors the cycle runs in reverse.

The discovery is the latest milestone in a long line of scientific inquiry that began in the 1920s when biochemists first recognized metabolic differences between cancer cells and normal cells. Scientists since have thought they could stop the growth of with drugs that only tumor-specific pathways, leaving normal cells unaffected.

Researchers have identified only a few such therapeutic windows, the latest of which appears to be the reverse Krebs cycle pathway identified by Dr. DeBerardinis and colleagues in this investigation.

"There is no pathway that has been more extensively studied over the years than the Krebs cycle," Dr. DeBerardinis said. "The fact that with relatively modest manipulation, it can run in reverse is incredibly fascinating."

Dr. James K.V. Willson, director of the Harold C. Simmons Comprehensive Cancer Center, said the findings are significant.

"We are learning that certain cancers have previously unrecognized mutations in genes controlling metabolism – and these abnormalities are providing new therapeutic opportunities," he said.

Explore further: Blocking cancer cell's energy generator could lead to new targeted treatments

Related Stories

Blocking cancer cell's energy generator could lead to new targeted treatments

August 18, 2011
Cancer Research UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones. The research is published in Nature yesterday.

Scientists discover new pathway to potential therapies for advanced prostate cancer

July 25, 2011
UT Southwestern Medical Center researchers have narrowed the potential drug targets for advanced prostate cancer by demonstrating that late-stage tumors are driven by a different hormonal pathway than was thought previously.

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.